The minimal active human SVA retrotransposon requires only the 5′-Hexamer and Alu-like domains

Molecular and Cellular Biology

Volumn 32, Issue 22, 2012, Pages 4718-4726

  Hancks, Dustin C ^a,b   Mandal, Prabhat K ^a   Cheung, Ling E ^a   Kazazian, Haig H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ORF2 PROTEIN; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALU SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE DUPLICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LONG INTERSPERSED ELEMENT 1; LONG INTERSPERSED REPEAT; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROPOSON; RNA SPLICING; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84868693365     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00860-12     Document Type: Article

References (87)

1. Alisch RS, Garcia-Perez JL, Muotri AR, Gage FH, Moran JV. 2006. Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev. 20:210 -224.
2. Baillie JK, et al. 2011. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479:534 -537.
3. Bantysh OB, Buzdin AA. 2009. Novel family of human transposable elements formed due to fusion of the first exon of gene MAST2 with retrotransposon SVA. Biochemistry 74:1393-1399.
4. Beck CR, et al. 2010. LINE-1 retrotransposition activity in human genomes. Cell 141:1159 -1170.
5. Belancio VP, Hedges DJ, Deininger P. 2008. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res. 18:343-358.
6. Bennett E, Coleman L, Tsui C, Pittard W, Devine S. 2004. Natural genetic variation caused by transposable elements in humans. Genetics 168:933-951.
7. Boeke JD. 1997. LINEs and Alus-the polyA connection. Nat. Genet. 16:6 -7.
8. Brouha B, et al. 2003. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U. S. A. 100:5280 -5285.
9. Buzdin A, et al. 2002. A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3= terminus of L1. Genomics 80:402- 406.
10. Carbone L, et al. 2012. Centromere remodeling in Hoolock leuconedys (Hylobatidae) by a new transposable element unique to the gibbons. Genome Biol. Evol. 4:648-658.
11. Chen JM, Stenson PD, Cooper DN, Ferec C. 2005. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum. Genet. 117:411- 427.
12. Chimpanzee Sequencing and Analysis Consortium. 2005. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437:69-87.
13. Christensen SM, Eickbush TH. 2005. R2 target-primed reverse transcription: ordered cleavage and polymerization steps by protein subunits asymmetrically bound to the target DNA. Mol. Cell. Biol. 25:6617- 6628.
14. Comeaux MS, Roy-Engel AM, Hedges DJ, Deininger PL. 2009. Diverse cis factors controlling Alu retrotransposition: what causes Alu elements to die? Genome Res. 19:545-555.
15. Cost GJ, Feng Q, Jacquier A, Boeke JD. 2002. Human L1 element target-primed reverse transcription in vitro. EMBO J. 21:5899 -5910.
16. Coufal NG, et al. 2009. L1 retrotransposition in human neural progenitor cells. Nature 460:1127-1131.
17. Damert A, et al. 2009. 5=-transducing SVA retrotransposon groups spread efficiently throughout the human genome. Genome Res. 19:1992- 2008.
18. Deininger PL, Batzer MA. 1999. Alu repeats and human disease. Mol. Genet. Metab. 67:183-193.
19. Dewannieux M, Esnault C, Heidmann T. 2003. LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 35:41- 48.
20. Dombroski BA, Mathias SL, Nanthakumar E, Scott AF, Kazazian HH, Jr. 1991. Isolation of an active human transposable element. Science 254: 1805-1808.
21. Dombroski BA, Scott AF, Kazazian HH, Jr. 1993. Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc. Natl. Acad. Sci. U. S. A. 90: 6513-6517.
22. Doucet Al J, et al. 2010. Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet. 6:e1001150. doi:10.1371/journal.pgen.1001150.
23. Esnault C, Maestre J, Heidmann T. 2000. Human LINE retrotransposons generate processed pseudogenes. Nat. Genet. 24:363-367.
24. Ewing AD, Kazazian HH, Jr. 2010. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 20:1262-1270.
25. Feng Q, Moran JV, Kazazian HH, Jr, Boeke JD. 1996. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87:905-916.
26. Freeman JD, Goodchild NL, Mager DL. 1994. A modified indicator gene for selection of retrotransposition events in mammalian cells. Biotechniques 17:46, 48-49, 52.
27. Garcia-Perez JL, Doucet AJ, Bucheton A, Moran JV, Gilbert N. 2007. Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase. Genome Res. 17:602- 611.
28. Garcia-Perez JL, et al. 2007. LINE-1 retrotransposition in human embryonic stem cells. Hum. Mol. Genet. 16:1569 -1577.
29. Garcia-Perez JL, et al. 2010. Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature 466: 769-773.
30. Gemayel R, Vinces MD, Legendre M, Verstrepen KJ. 2010. Variable tandem repeats accelerate evolution of coding and regulatory sequences. Annu. Rev. Genet. 44:445- 477.
31. Gilbert N, Lutz S, Morrish TA, Moran JV. 2005. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol. 25:7780 -7795.
32. Goodier JL, Kazazian HH, Jr. 2008. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 135:23-35.
33. Goodier JL, Ostertag EM, Engleka KA, Seleme MC, Kazazian HH, Jr. 2004. A potential role for the nucleolus in L1 retrotransposition. Hum. Mol. Genet. 13:1041-1048.
34. Han K, et al. 2007. Mobile DNA in Old World monkeys: a glimpse through the rhesus macaque genome. Science 316:238 -240.
35. Han K, et al. 2008. L1 recombination-associated deletions generate human genomic variation. Proc. Natl. Acad. Sci. U. S. A. 105:19366 -19371.
36. Hancks DC, Ewing AD, Chen JE, Tokunaga K, Kazazian HH, Jr. 2009. Exon-trapping mediated by the human retrotransposon SVA. Genome Res. 19:1983-1991.
37. Hancks DC, Goodier JL, Mandal PK, Cheung LE, Kazazian HH. Jr. 2011 Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum. Mol. Genet. 20:3386 -3400.
38. Hancks DC, Kazazian HH, Jr. 2010. SVA retrotransposons: evolution and genetic instability. Semin. Cancer Biol. 20:234 -245.
39. Hancks DC, Kazazian HH, Jr. 2012. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 22:191-203.
40. Holmes SE, Singer MF, Swergold GD. 1992. Studies on p40, the leucine zipper motif-containing protein encoded by the first open reading frame of an active human LINE-1 transposable element. J. Biol. Chem. 267: 19765-19768.
41. Hormozdiari F, et al. 2011. Alu repeat discovery and characterization within human genomes. Genome Res. 21:840-849.
42. Huang CR, et al. 2010. Mobile interspersed repeats are major structural variants in the human genome. Cell 141:1171-1182.
43. Iskow RC, et al. 2010. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141:1253-1261.
44. Jurka J, et al. 2005. Repbase Update, a database of eukaryotic repetitive elements. Cytogenet. Genome Res. 110:462- 467.
45. Kano H, et al. 2009. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 23:1303-1312.
46. Karakoc E, et al. 2012. Detection of structural variants and indels within exome data. Nat. Methods 9:176 -178.
47. Kazazian HH, Jr et al. 1988. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332:164 -166.
48. Kent WJ. 2002. BLAT-The BLAST-Like Alignment Tool. Genome Res. 12:656-664.
49. Kimberland ML, et al. 1999. Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum. Mol. Genet. 8:1557-1560.
50. Kobayashi K, et al. 1998. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394:388 -392.
51. Konkel MK, Batzer MA. 2010. A mobile threat to genome stability: the impact of non-LTR retrotransposons upon the human genome. Semin. Cancer Biol. 20:211-221.
52. Lander E, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860 -921.
53. Lavie L, Maldener E, Brouha B, Meese EU, Mayer J. 2004. The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res. 14:2253- 2260.
54. Locke DP, et al. 2011. Comparative and demographic analysis of orangutan genomes. Nature 469:529 -533.
55. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. 1993. Reverse transcription of R2BmRNAis primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 72:595- 605.
56. Martin SL, Bushman FD. 2001. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol. Cell. Biol. 21:467- 475.
57. Mathias SL, Scott AF, Kazazian HH, Jr, Boeke JD, Gabriel A. 1991. Reverse transcriptase encoded by a human transposable element. Science 254:1808 -1810.
58. Matsui T, et al. 2010. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464:927-931.
59. Mills RE, Bennett EA, Iskow RC, Devine SE. 2007. Which transposable elements are active in the human genome? Trends Genet. 23:183-191.
60. Mills RE, et al. 2006. Recently mobilized transposons in the human and chimpanzee genomes. Am. J. Hum. Genet. 78:671- 679.
61. Moran JV, et al. 1996. High frequency retrotransposition in cultured mammalian cells. Cell 87:917-927.
62. Muotri AR, et al. 2005. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435:903-910.
63. Ono M, Kawakami M, Takezawa T. 1987. A novel human nonviral retroposon derived from an endogenous retrovirus. Nucleic Acids Res. 15:8725- 8737.
64. Ostertag E, Kazazian H, Jr. 2001. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 35:501-538.
65. Ostertag EM, Goodier JL, Zhang Y, Kazazian HH, Jr. 2003. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 73:1444 -1451.
66. Ostertag EM, Prak ET, DeBerardinis RJ, Moran JV, Kazazian HH, Jr. 2000. Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res. 28:1418 -1423.
67. Raiz J, et al. 2012. The non-autonomous retrotransposon SVA is transmobilized by the human LINE-1 protein machinery. Nucleic Acids Res. 40:1666 -1683.
68. Rowe HM, et al. 2010. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463:237-240.
69. Sassaman DM, et al. 1997. Many human L1 elements are capable of retrotransposition. Nat. Genet. 16:37- 43.
70. Scott AF, et al. 1987. Origin of the human L1 elements: proposed progenitor genes deduced from a consensusDNAsequence. Genomics 1:113- 125.
71. Sen SK, et al. 2006. Human genomic deletions mediated by recombination between Alu elements. Am. J. Hum. Genet. 79:41-53.
72. Shen L, et al. 1994. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. J. Biol. Chem. 269:8466-8476.
73. Solyom S, et al. 2012. Pathogenic orphan transduction created by a nonreference LINE-1 retrotransposon. Hum. Mutat. 33:369 -371.
74. Strichman-Almashanu LZ, et al. 2002. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res. 12:543-554.
75. Swergold GD. 1990. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol. Cell. Biol. 10:6718-6729.
76. Taniguchi-Ikeda M, et al. 2011. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478: 127-131.
77. van den Hurk JA, et al. 2007. L1 retrotransposition can occur early in human embryonic development. Hum. Mol. Genet. 16:1587-1592.
78. van der Klift HM, Tops CM, Hes FJ, Devilee P, Wijnen JT. 2012. Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome. Hum. Mutat. 33: 1051-1055.
79. Ventura M, et al. 2011. Gorilla genome structural variation reveals evolutionary parallelisms with chimpanzee. Genome Res. 21:1640 -1649.
80. Wallace MR, et al. 1991. A de novo Alu insertion results in neurofibromatosis type 1. Nature 353:864-866.
81. Wang H, et al. 2005. SVA elements: a hominid-specific retroposon family. J. Mol. Biol. 354:994 -1007.
82. Wei W, et al. 2001. Human L1 retrotransposition: cis preference versus trans complementation. Mol. Cell. Biol. 21:1429 -1439.
83. Wimmer K, Callens T, Wernstedt A, Messiaen L. 2011. The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion. PLoS Genet. 7:e1002371. doi:10.1371/journal.pgen.1002371.
84. Witherspoon D, et al. 2010. Mobile element scanning (ME-Scan) by targeted high-throughput sequencing. BMC Genomics 11:410. doi: 10.1186/1471-2164-11-410.
85. Xing J, et al. 2006. Emergence of primate genes by retrotransposonmediated sequence transduction. Proc. Natl. Acad. Sci. U. S. A. 103: 17608-17613.
86. Zabolotneva AA, et al. 2012. Transcriptional regulation of humanspecific SVAF1 retrotransposons by cis-regulatory MAST2 sequences. Gene 505:128 -136.
87. Zhu ZB, Hsieh SL, Bentley DR, Campbell RD, Volanakis JE. 1992. A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J. Exp. Med. 175:1783-1787.